Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
Authors
Keywords
-
Journal
Science Immunology
Volume 6, Issue 58, Pages eabe2933
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-05-01
DOI
10.1126/sciimmunol.abe2933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Focus on the Role of NLRP3 Inflammasome in Diseases
- (2020) Roberta Fusco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibiting the NLRP3 Inflammasome
- (2020) Lina Y. El-Sharkawy et al. MOLECULES
- ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
- (2019) Guangming Ren et al. EMBO JOURNAL
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- Structural Basis of BRCC36 Function in DNA Repair and Immune Regulation
- (2019) Julius Rabl et al. MOLECULAR CELL
- Regulation of oxidized LDL-induced inflammatory process through NLRP3 inflammasome activation by the deubiquitinating enzyme BRCC36
- (2019) Mohit Singh et al. INFLAMMATION RESEARCH
- Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
- (2019) Tatjana Meyer et al. LEUKEMIA
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
- (2019) Lieselotte Vande Walle et al. PLOS BIOLOGY
- The BRCC3 regulated by Cdk5 promotes the activation of neuronal NLRP3 inflammasome in Parkinson’s disease models
- (2019) Xinyu Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity
- (2018) Li Zhang et al. Nature Communications
- LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis
- (2018) Jiacai Hu et al. BIOCHIMIE
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
- (2017) Jing Li et al. Nature Chemical Biology
- Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases
- (2017) Linda Lauinger et al. Nature Chemical Biology
- Deubiquitylating enzymes and drug discovery: emerging opportunities
- (2017) Jeanine A. Harrigan et al. NATURE REVIEWS DRUG DISCOVERY
- Role for dithiolopyrrolones in disrupting bacterial metal homeostasis
- (2017) Andrew N. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and characterization of Streptomyces flavogriseus NJ-4 as a novel producer of actinomycin D and holomycin
- (2017) Zhaohui Wei et al. PeerJ
- Human Monocytes Engage an Alternative Inflammasome Pathway
- (2016) Moritz M. Gaidt et al. IMMUNITY
- Targeted inhibition of the COP9 signalosome for treatment of cancer
- (2016) Anita Schlierf et al. Nature Communications
- Higher-Order Assembly of BRCC36–KIAA0157 Is Required for DUB Activity and Biological Function
- (2015) Elton Zeqiraj et al. MOLECULAR CELL
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro
- (2015) Ziwei Tu et al. Radiation Oncology
- Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
- (2014) R Levy et al. ANNALS OF THE RHEUMATIC DISEASES
- Insights into the Mechanism of Deubiquitination by JAMM Deubiquitinases from Cocrystal Structures of the Enzyme with the Substrate and Product
- (2014) Rashmi K. Shrestha et al. BIOCHEMISTRY
- Toxicity of Bioactive and Probiotic Marine Bacteria and Their Secondary Metabolites in Artemia sp. and Caenorhabditis elegans as Eukaryotic Model Organisms
- (2013) Anna Katrin Neu et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
- (2013) N. Kayagaki et al. SCIENCE
- A BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses
- (2013) Hui Zheng et al. Cell Reports
- Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
- (2012) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome
- (2012) Gloria Lopez-Castejon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
- (2012) Bénédicte F. Py et al. MOLECULAR CELL
- Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex
- (2010) Jeffrey Patterson-Fortin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses
- (2010) D. Gris et al. JOURNAL OF IMMUNOLOGY
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton
- (2009) Yifeng Jia et al. CELL STRESS & CHAPERONES
- Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
- (2009) Susannah D. Brydges et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started